Houston pharma company taps new CFO
There's a new CFO in the Houston pharmaceutical world.
Jonathan Foster was named CFO and executive vice president of Houston-based Moleculin Biotech Inc. (Nasdaq: MBRX), according to a release. His appointment was effective Aug. 22.
"We are very pleased to announce that Jon Foster has agreed to serve as CFO as we continue to attract seasoned executives with successful track records to our growing company," Walter Klemp, chairman and acting CEO, said in a statement.
Moleculin was formed out of...